Latest Lead News

Duratec Limited has announced a fully franked final dividend of AUD 0.025 per share for the fiscal year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 5% discount on new shares.

Airtasker Limited is set to release its FY25 financial results on 28 August 2025, accompanied by an investor webinar featuring CEO Tim Fung and CFO Mahendra Tharmarajah. The announcement comes as the company highlights its new partnership with the Visa Cash App Racing Bulls Formula One Team.

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

Invictus Energy has forged a landmark partnership with Al Mansour Holdings, securing a strategic 19.9% stake and up to US$500 million in funding to advance its Cabora Bassa Project and expand into African upstream oil and gas markets.

archTIS Limited has reported FY25 results with solid ARR growth and completed a transformative acquisition of Spirion LLC, significantly boosting its US market presence and product suite. The company is raising $20.5 million to fund this expansion and accelerate growth.

Kinatico has reported a robust FY25 with 12% revenue growth to $32.1 million, driven by a 54% surge in SaaS revenue and the launch of its new Kinatico Compliance product. The company’s strong cash flow and expanding market position signal a promising future in the evolving RegTech landscape.

WAM Research Limited reported a robust 22.4% increase in its investment portfolio for FY2025, significantly outperforming key ASX indices, while maintaining a high dividend yield of 8.1%.

NeuroScientific Biopharmaceuticals reports encouraging early clinical results for its StemSmart™ MSC therapy in preventing and treating kidney transplant rejection and injury.

Altair Minerals is escalating its dispute with BHP over the undervaluation of its Olympic Domain Project by proceeding to South Australia’s Wardens Court. The junior explorer aims to defend the strategic and exploration value of its land amid ongoing negotiations with other majors.

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

RAM Essential Services Property Fund reported solid FY25 results, highlighting portfolio growth, strategic capital recycling, and a clear transition towards a pure healthcare real estate focus.